Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Jul 21, 2021
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- Reminder Regarding Recipient and Applicant Grants Policy Related Inquiries
National Institutes of Health
General Notices
- Notice of Information: Guidance Regarding Minimum Level of Effort for NCI-Funded Awards
National Cancer Institute
- Solicitation of Nominations for the 2022 National Institute of Neurological Disorders and Stroke (NINDS) Landis Award for Outstanding Mentorship
National Institute of Neurological Disorders and Stroke
- Request for Information (RFI): National Institute of Dental and Craniofacial Research (NIDCR) Strategic Plan Fiscal Years 2021-2026
National Institute of Dental and Craniofacial Research
Notice of Changes to Funding Opportunities
- Notice of Clarification of Responsiveness to NIAAA RFA-AA-21-002 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed)"
National Institute on Alcohol Abuse and Alcoholism
- Notice of Clarification of Responsiveness to NIAAA RFA-AA-21-003 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed)"
National Institute on Alcohol Abuse and Alcoholism
- Notice of Clarification of Responsiveness to NIAAA RFA-AA-21-004 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)"
National Institute on Alcohol Abuse and Alcoholism
- Notice of Correction of PAR-21-030, "Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)"
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Notice of NIAMS Participation in RFA-NS-20-008, "HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)"
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Notice of NIAMS Participation in RFA-NS-20-010, "HEAL Initiative: HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)"
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Notice of Change to Award Budget and Clarification regarding Inclusion of KUH Disciplines for PAR-20-220, Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C-Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Change to NOT-EB-20-017, "Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications"
National Institute of Biomedical Imaging and Bioengineering
- Notice of Early Expiration to NOT-EB-20-022, "Notice of Special Interest (NOSI): Administrative Supplement for Providing Travel Support for Awardees to Attend the Annual NIH Synthetic Biology Consortium Meeting (Admin Supp)"
National Institute of Biomedical Imaging and Bioengineering
- Notice of NHLBI Participation in NOT-HD-21-027 "Notice of Special Interest (NOSI): Navigating Pediatric to Adult Health Care: Lost in Transition"
National Heart, Lung, and Blood Institute
- Notice of Change in Expiration Date for AHRQ PA-21-266, Patient Safety Learning Laboratories: Advancing Patient Safety through Design, Systems Engineering, and Health Services Research (R18 Clinical Trial Optional)
Agency for Healthcare Research and Quality
- Notice of Change to Expiration of PAR-18-894, "Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed)"
National Institute of Mental Health
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Partnership between Research Centers in Minority Institutions (RCMI) and Alcohol Research Centers (U54 Clinical Trial Optional)
National Institute on Alcohol Abuse and Alcoholism
Notices of Special Interest
- Notice of Special Interest (NOSI): International Research Collaboration on Drug Abuse and Addiction Research
National Institute on Drug Abuse
- Notice of Special Interest: Advancing Research in Gastrointestinal Dysfunction in People with Neurodevelopmental Disorders
National Institute of Neurological Disorders and Stroke
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Funding Opportunities
- Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed)
National Human Genome Research Institute
National Cancer Institute
National Institute of Allergy and Infectious Diseases
- NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional)
- NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
- NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
National Institute of Neurological Disorders and Stroke
- Cancer Target Discovery and Development (CTD2) (U01 Clinical Trial Not Allowed)
National Cancer Institute
- Aging Research in Animals (ARIA): Promoting Rigorous Research on Behavioral and Social Processes (R61/R33 Clinical Trial Not Allowed)
National Institute on Aging
- Elucidating the Roles of Transposable Elements in AD/ADRD and Aging (R01 Clinical Trial Not Allowed)
National Institute on Aging
- Primary Care-Based Screening and Intervention Development for Prevention of Abuse in Older and Vulnerable Adults in the Context of Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Required)
National Institute on Aging
- Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed)
- Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (CAP-IT DRCC) (U24 Clinical Trial Not Allowed)
National Cancer Institute
- Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed)
- Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Biostatistics Research Center (U01 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
- Continuation of The Collaborative Islet Transplantation Registry (U01 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
- Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Neurological Disorders and Stroke
- Network of the National Library of Medicine All of Us Program Center (U24) (Clinical Trial Optional)
National Library of Medicine
- BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Lynn Hudachek at lynn-hudachek@uiowa.edu.